Astra Zeneca Clams Up on COVID Vaccine Safety Details, Alarming Scientists

A patient in the Astra Zeneca COVID-19 vaccine trials experienced a serious neurological reaction, triggering the company to halt its testing while a review of the case was made. CEO Pascal Soriot talked about it in a closed meeting with its investment bank J.P. Morgan, but gave no public details on the patient’s condition, not even to the company’s stockholders. Adding more fuel to the fire, Pfizer announced Saturday, September 12, 2020, that it was expanding its clinical trials...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports